Sildenafil & vardenafil remain script only

The TGA has knocked back applications for the drugs to go OTC, citing need for medical practitioners to be involved Applications were submitted for both sildenafil (50 mg) and PDE5 inhibitor vardenafil (up to 10mg) by their respective sponsors for the TGA to consider downscheduling the drugs from S4 to S3. But this month both